Biocryst Pharmaceuticals (BCRX) Q4 2024 Earnings

Nov 4Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.31
-0.23
-0.14
-0.06

Details

Expected EPS
-0.068
Actual EPS
-0.07
Surprise EPS
-0
Surprise Percent
-2.94%

Description

⁨Biocryst Pharmaceuticals⁩ (⁦BCRX⁩) has reported earnings of ⁦-0.07⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts